Compliance Best Practices For Tianeptine Research

Tianeptine research compliance in 2026 means 6 checks. Confirm your state allows possession, match every lot to its certificate of analysis (COA) and safety data sheet (SDS), and store it under lock with a named access list. Then cover it in your Chemical Hygiene Plan, log every use and disposal, and keep all wording research-use only. Federally, tianeptine isn't a controlled substance yet. That may not last. On July 8, 2026, the DEA proposed placing it in Schedule I, and a final rule would require a DEA registration for anyone who handles it, labs included.

Research use only: Nordic Chems supplies tianeptine for laboratory and analytical work. It isn't for human or animal consumption, and this article isn't legal advice.

What Is Tianeptine Research Compliance?

Tianeptine research compliance is the set of legal, safety and record-keeping controls a lab follows while it buys, stores, uses and disposes of tianeptine as a research material. It covers state controlled-substance law, OSHA's Laboratory Standard, lot-level identity records and research-use-only handling. In 2026 it also means planning for possible federal Schedule I control.

Older guides also describe outdated receptor science, including the first version of this post, which framed tianeptine around serotonin receptors. A 2014 Columbia University study by Gassaway and colleagues in Translational Psychiatry screened tianeptine against 51 human central nervous system receptors and transporters. Only 1 produced a hit: the mu-opioid receptor, where tianeptine bound with a Ki of 383 nM and worked as a full agonist.

The serotonin receptors and the serotonin transporter in that panel came back negative. The DEA's proposal points the same way. It describes tianeptine as pharmacologically similar to other mu-opioid agonists and would list it in the opioids category of Schedule I.

Is Tianeptine A Controlled Substance?

Not federally, as of this October 2026 update. The DEA has proposed Schedule I, and its notice lists 15 states that had already controlled tianeptine or banned its sale.

The federal process has moved in 4 steps.

• September 7, 2023: the DEA asked HHS for a scientific and medical evaluation.
• July 18, 2025: HHS recommended Schedule I for tianeptine and its salts.
• July 8, 2026: the DEA published its proposed Schedule I rule (91 FR 42150, Docket DEA1596).
• August 7, 2026: the public comment period closed. No final rule had been published as of October 12, 2026.

Salt form doesn't change the answer. The proposal covers tianeptine's salts, so tianeptine sodium and tianeptine sulfate would be treated the same.

The FDA's position hasn't moved either. Its tianeptine warning, dated May 8, 2025, says tianeptine isn't approved for any medical use. The same notice says it isn't generally recognized as safe for use in food and doesn't meet the statutory definition of a dietary ingredient.

For your own state, read the controlled-substance statute or the schedule your board of pharmacy publishes, then compare it with our state-by-state restrictions guide. State schedules change between updates, so record the date you checked.

What Changes If The DEA Finalizes Schedule I?

Anyone who handles tianeptine would need a DEA registration. The proposal covers research, chemical analysis, instructional work and possession, so analytical and teaching labs are in scope too.

If the rule is finalized as proposed, 6 requirements would follow.

• Registration: a lab without a Schedule I research registration would have to apply and couldn't keep handling tianeptine unless the DEA approves the application. A lab already researching tianeptine under a registration for another Schedule I substance would get 90 calendar days after the rule takes effect to file. It could continue that research unless the DEA moves to deny the application.
• Stock on hand: anyone unwilling or unable to register must surrender or transfer all of it to a DEA registrant before the effective date. Disposal follows 21 CFR part 1317.
• Security: storage would have to meet 21 CFR 1301.71 to 1301.76.
• Inventory and records: an initial inventory on the first day of handling, a new one every 2 years, and records under 21 CFR part 1304.
• Import and export: shipments into or out of the U.S. would have to comply with 21 U.S.C. 952, 953, 957 and 958.
• Sales: the Controlled Substances Act doesn't allow retail sale of a Schedule I substance to the general public.

Start now. Ask your controlled-substances or EHS office whether your institution already holds a Schedule I research registration. Keep a running inventory today so your first DEA inventory isn't rebuilt from memory. Our guide to transitioning a research program covers registration and the 3 paths for inventory you already hold.

6 Checks Every Tianeptine Lab Should Run Now

Run them in order and date each one. Every check leaves a record you'll want if an auditor, your EHS office or the DEA asks how a lot was handled.

1. Confirm Your State Allows It Before You Order

State law applies whatever the label says. Check your state's controlled-substance schedule, then note the date and source in your lot file. Nordic Chems won't sell tianeptine to buyers in the states listed under Regulated States on each tianeptine product page. Treat any vendor's list as a backstop. The legal check is yours.

2. Match Every Lot To Its COA And SDS On Arrival

Check 4 things before a container goes on the shelf: the salt form on the label, the batch or lot number, the COA for that lot and the current SDS. Salt forms aren't interchangeable on paper. The current tianeptine sulfate COA from Nordic Chems lists the salt as C21H27ClN2O8S2 at 535.0 g/mol, while the tianeptine sodium listing gives 458.9 g/mol. A COA whose formula or weight doesn't match the salt on your label is a reason to quarantine the lot.

A usable COA identifies the testing lab and gives the report number, the batch or lot, the sample-received and analysis dates, the method, and the identity and purity results.

Report 13589 on the tianeptine sulfate listing shows how that looks. It carries BioRegen's contact and verification addresses, and Nordic Chems names BioRegen Labs in Houston as a testing partner. The sample was received on July 9, 2026 and analyzed on July 16, 2026 by ultra-high-performance liquid chromatography with mass spectrometry. The report shows an identity match and 99.4% purity against a specification of more than 99%, and a lab can confirm it through BioRegen's verification page.

Ask for the COA tied to your order. Email your order number and Nordic Chems matches the COA to your exact batch.

Then file the SDS with the lot. For incoming hazardous chemicals, OSHA's Laboratory Standard requires employers to keep arriving SDSs readily accessible to lab staff and to keep container labels intact (29 CFR 1910.1450(h)). Apply the same rule to tianeptine.

3. Lock It Up And Name Who Can Open It

Store tianeptine in a locked cabinet with a written list of named, trained users, and keep it in its original labeled container. Orders from Nordic Chems ship induction-sealed and tamper-evident, so a broken seal on arrival is a receiving exception: log it and contact the supplier before use. For conditions, follow the SDS. The tianeptine sulfate SDS calls for a tightly sealed container in a cool, well-ventilated area, away from direct sunlight and ignition sources. Our guide to storage conditions covers shelf life. If Schedule I is finalized, that lock becomes a federal security requirement, so build the habit now.

4. Write Tianeptine Into Your Chemical Hygiene Plan

Your lab's Chemical Hygiene Plan is where tianeptine's procedures belong. OSHA's Laboratory Standard requires a written plan wherever a lab uses hazardous chemicals (29 CFR 1910.1450(e)). The plan has to cover standard operating procedures, control measures and the cases that need prior approval, and it gets reviewed at least once a year.

Add 3 items for tianeptine: an SOP for weighing and solution work, a prior-approval step for any new procedure, and the PPE from section 8 of the SDS. That section lists suitable gloves, protective clothing, safety glasses, and a P3 respirator filter when dust is generated. Train each named user on the SOP and the SDS first-aid section before they get a key.

IRB approval isn't the gate for this work. Institutional review boards review research with human subjects, and Nordic Chems sells tianeptine for laboratory and analytical work only, never for administration to people or animals. Earlier versions of this post said every tianeptine experiment needed IRB approval. That advice was wrong for bench work.

5. Log Every Use, Transfer And Disposal

Keep a running log with the date, user, lot number, amount removed, balance left and the protocol it went to. Reconcile it against the container each month. If Schedule I is finalized, the DEA would require an initial inventory, a new one every 2 years and records under 21 CFR part 1304. A clean log turns all 3 into a copy job.

Route unused material and contaminated items through your EHS office's chemical waste program. The SDS says to keep the product out of drains and puts the hazardous-waste decision on the waste generator under EPA and state rules. Record the date, amount, method and pickup ID for each disposal.

6. Keep All Wording Research-Use Only

Purchase justifications, SOPs, inventory labels and publications should all describe laboratory work, in the same terms your supplier uses. For example, the Nordic Chems tianeptine listings describe the material as a packaged chemical reference material for analytical identification, method development, calibration, validation or educational laboratory work. Use those categories in your own paperwork. Mixed language invites questions about intended use.

Why Isn't A Research-Use Label Enough?

Because FDA rules judge intended use by objective intent, and a label is only one piece of evidence. Under 21 CFR 201.128, that intent can be shown by labeling claims, advertising, oral or written statements, the design or composition of the product, or the circumstances surrounding its distribution.

The enforcement record shows how that works. In August 2024, the FDA published a 15-year debarment order against a tianeptine seller (Federal Register document 2024-18268). The order says his websites described the tianeptine as for research purposes only and not intended for human consumption. He sold it to customers for their personal use anyway. He'd been convicted on 3 federal felony counts.

For a lab, the lesson is to buy from a vendor that screens buyers and refuses orders outside research. Keep your own records consistent with laboratory work too. Nordic Chems keeps a no-sell list and permanently rejects orders when it has reasonable suspicion of use outside research. Its terms allow a verification and background check on any buyer before a sale, and its tianeptine listings state pack quantities for documentation and inventory control only. A vendor that will sell to anyone who ticks a research-use box is a vendor to drop.

What Goes In A Tianeptine Lot File?

A lot file is 1 folder per lot that proves where the material came from, what it is, who handled it and where it went. Keep these 9 records in it.

• Order record: order number, date, vendor, salt form and amount.
• COA for that lot: lab, report number, batch or lot, received and analysis dates, method, and identity and purity results.
• SDS: the current revision, with its date.
• Receiving check: date received, seal condition, and the label matched to the COA.
• Jurisdiction check: your state's status on the order date and the source you checked.
• Storage record: location, lock and the named access list.
• Usage log: date, user, amount removed, balance and protocol ID.
• Disposal record: date, amount, method and EHS pickup ID.
• DEA registration number, if the Schedule I rule is finalized.

The first 3 records come from your supplier. If a vendor can't produce them for your exact lot, the file has a gap before you open the container.

Tianeptine research compliance won't sit still in 2026, so date every check and recheck your state before each order. Watch the Federal Register for a final DEA rule. If it matches the proposal, labs without a Schedule I registration would have to stop handling tianeptine on its effective date unless the DEA has approved their application.

Research Use Only

Nordic Chems supplies tianeptine strictly for laboratory research and analytical use. It isn't for human or animal consumption, ingestion or administration, and the FDA hasn't approved it for any medical use. This article is general information for laboratories, not legal advice. Rules differ by state and can change, including if the DEA finalizes its Schedule I proposal. Confirm current requirements with your institution's compliance office or counsel before you buy, store or use tianeptine.

Frequently Asked Questions

What does tianeptine research compliance require?

It requires 6 checks: confirm your state allows possession, match each lot to its COA and SDS, store it locked with a named access list, cover it in your Chemical Hygiene Plan, log every use and disposal, and keep all wording research-use only. Labs should also prepare for the DEA's July 8, 2026 proposal to place tianeptine in Schedule I.

Is tianeptine a federally controlled substance?

Not yet. The DEA proposed placing tianeptine and its salts in Schedule I on July 8, 2026 (91 FR 42150), and the comment period closed on August 7, 2026. As of October 12, 2026, no final rule had been published.

Do labs need a DEA registration for tianeptine research?

Not under federal law today, though a state that schedules tianeptine may require its own license. If the Schedule I rule is finalized, anyone who handles tianeptine would need a DEA registration. A lab already researching tianeptine under a registration for another Schedule I substance would get 90 calendar days after the rule takes effect to file.

Does a research-use-only label make tianeptine legal in my state?

No. A state controlled-substance schedule applies to the material itself, whatever the label says. Check your state's statute or board of pharmacy before each order, and record the date and source in your lot file.

What should a tianeptine COA include?

It should identify the testing lab and give the report number, batch or lot number, sample-received and analysis dates, method, and the identity and purity results. The tianeptine sulfate COA on Nordic Chems' listing, report 13589, shows an identity match and 99.4% purity by liquid chromatography with mass spectrometry. Match the salt and lot on the COA to your label before the container goes into storage.

Is IRB approval part of tianeptine research compliance?

Not for bench work. Institutional review boards review research with human subjects, and Nordic Chems sells tianeptine for laboratory and analytical work only. That work runs under your lab's Chemical Hygiene Plan, which OSHA's Laboratory Standard requires wherever a lab uses hazardous chemicals.

How should a lab dispose of unused tianeptine?

Send it through your EHS office's chemical waste program and keep it out of drains, as the SDS directs. If the Schedule I rule is finalized, anyone who can't register must surrender or transfer remaining stock to a DEA registrant before the effective date. Record the date, amount and method each time, because disposal records are part of tianeptine research compliance.